Editorial: Are beta-blockers on the therapeutic horizon for ovarian cancer treatment?

Abstract

 Widely used medications for other disease processes, such as beta-blockers used for the management of hypertension, may provide therapeutic potential in patients with cancer, perhaps by altering the tumor microenvironment. The article by Watkins et al in the current issue performed a comprehensive review of beta-blocker use in women with ovarian cancer, and identified nonselective beta-blockers associated with longer overall survival.